Inventor
Bruno Simoneau
Inventor
Laval, CA
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds11%
C07KPeptides2%
C12NMicroorganisms or enzymes1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
9,399,645'Inhibitors of HIV replication'20168,841,331'Inhibitors of human immunodeficiency virus replication'20148,710,230'Inhibitors of human immunodeficiency virus replication'20148,461,180'Inhibitors of human immunodeficiency virus replication'20138,377,960'Inhibitors of human immunodeficiency virus replication'20138,354,429'Inhibitors of human immunodeficiency virus replication'20138,338,441'Inhibitors of human immunodeficiency virus replication'20128,198,458'Non-nucleoside reverse transcriptase inhibitors'20127,956,068'Inhibitors of human immunodeficiency virus replication'20117,642,277'Non-nucleoside reverse transcriptase inhibitors'20107,569,723'Benzoic acid derivatives as non nucleoside reverse-transcriptase inhibitors'20097,517,998'Non nucleoside reverse transcriptase inhibitors'20097,323,567'RSV polymerase inhibitors'20087,300,948'Alkynyl compounds as non nucleoside reverse transcriptase inhibitors'20077,273,861'Non-nucleoside reverse transcriptase inhibitors'20076,806,265'Non-nucleoside reverse transcriptase inhibitors'20046,767,991'Hepatitis C inhibitor peptides'20046,706,706'Non-nucleoside reverse transcriptase inhibitors'20046,673,791'Non-nucleoside reverse transcriptase inhibitors'20046,458,959'Anti-herpesvirus compounds and methods for identifying, making and using same'20026,420,359'Non-nucleoside reverse transcriptase inhibitors'20026,348,477'Anti-herpesvirus compounds and methods for identifying, making and using same'20026,323,180'Hepatitis C inhibitor tri-peptides'20016,323,202'HSV primase inhibitors'20016,288,091'Antiherpes virus compounds and methods for their preparation and use'20016,057,451'Anti-herpesvirus compounds and methods for identifying, making and using same'20005,693,619'Method of using renin inhibiting N-(2-amino-2-oxoethyl) butanediamide derivatives'19975,565,476'N-(hydroxyethyl)butanediamide derivatives'19965,554,634'N-(hydroxyethyl)butanediamide derivatives'19965,541,163'Renin inhibiting N-(2-amino-2-oxoethyl)butanediamide derivatives'19965,523,315'N-(hydroxyethyl)butanediamide derivatives'19965,354,767'Renin inhibiting polyhydroxy-monoamides'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2016Based in Laval, CA· patent location history
1996–1997Patents assigned to BIO MEGA BOEHRINGER INGELHEIM (5)· patent assignee history
2001–2008Patents assigned to BOEHRINGER INGELHEIM CA LTD (9)· patent assignee history
2004–2016Patents assigned to BOEHRINGER INGELHEIM INT (9)· patent assignee history
2012–2014Patents assigned to GILEAD SCIENCES INC (6)· patent assignee history
2012–2013Patents assigned to SIMONEAU BRUNO (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM CA LTD | 9 | 2001–2008 |
| BOEHRINGER INGELHEIM INT | 9 | 2004–2016 |
| GILEAD SCIENCES INC | 6 | 2012–2014 |
| BIO MEGA BOEHRINGER INGELHEIM | 5 | 1996–1997 |
| SIMONEAU BRUNOself | 5 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Laval, CA | 32 | 1994–2016 |